Tarsus Pharmaceuticals Inc. Revenue 2020–2025
Tarsus Pharmaceuticals Inc. annual/quarterly revenue history and growth rate from 2020 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Tarsus Pharmaceuticals Inc. revenue for the quarter ending March 31, 2026 was 162.1 M, a 106.87% increase year-over-year.
- Tarsus Pharmaceuticals Inc. revenue for the twelve months ending March 31, 2026 was 461.7 M, a 289.94% increase year-over-year.
- Tarsus Pharmaceuticals Inc. annual revenue for 2025 was 451.4 M, a 146.71% increase from 2024.
- Tarsus Pharmaceuticals Inc. annual revenue for 2024 was 183.0 M, a 948.62% increase from 2023.
- Tarsus Pharmaceuticals Inc. annual revenue for 2023 was 17.4 M, a 32.42% decrease from 2022.
- Tarsus Pharmaceuticals Inc. annual revenue for 2022 was 25.8 M.
Tarsus Pharmaceuticals Inc. (TARS) — Frequently Asked Questions
Tarsus Pharmaceuticals Inc. (TARS) is a publicly traded US company. It has a market capitalization of $2.66B. In fiscal 2025 it reported revenue of $451M and net income of -$66M. Explore TARS's stock price, financial statements, earnings history, margins and key ratios below.
What is Tarsus Pharmaceuticals Inc.'s market cap?
Tarsus Pharmaceuticals Inc. (TARS) has a market capitalization of $2.66B.
What is the TARS stock price?
TARS trades at $63.64 (+3.87% on the day).
How much revenue does Tarsus Pharmaceuticals Inc. make?
Tarsus Pharmaceuticals Inc. reported revenue of $451M in fiscal 2025.
Is TARS profitable?
In fiscal 2025, Tarsus Pharmaceuticals Inc. reported net income of -$66M.